News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,508 Results
Type
Article (10804)
Company Profile (8)
Press Release (260696)
Section
Business (78402)
Career Advice (262)
Deals (20280)
Drug Delivery (45)
Drug Development (35845)
Employer Resources (23)
FDA (7577)
Job Trends (6406)
News (147323)
Policy (18197)
Tag
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
Academia (503)
Adcomms (3)
Allergies (33)
Alliances (16464)
ALS (25)
Alzheimer's disease (534)
Antibody-drug conjugate (ADC) (27)
Approvals (7646)
Artificial intelligence (46)
Autoimmune disease (5)
Automation (4)
Bankruptcy (210)
Best Places to Work (5577)
BIOSECURE Act (9)
Biosimilars (41)
Biotechnology (10)
Bladder cancer (34)
Brain cancer (11)
Breast cancer (116)
Cancer (909)
Cardiovascular disease (50)
Career advice (236)
Career pathing (1)
CAR-T (45)
Cell therapy (153)
Cervical cancer (9)
Clinical research (30375)
Collaboration (264)
Compensation (175)
Complete response letters (11)
COVID-19 (899)
CRISPR (14)
C-suite (66)
Cystic fibrosis (34)
Data (1083)
Denatured (1)
Depression (17)
Diabetes (123)
Diagnostics (2848)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (27)
Drug pricing (58)
Drug shortages (17)
Duchenne muscular dystrophy (40)
Earnings (41129)
Editorial (15)
Employer branding (1)
Employer resources (21)
Events (37171)
Executive appointments (245)
FDA (8191)
Featured Employer (2)
Frontotemporal dementia (3)
Funding (210)
Gene editing (33)
Generative AI (4)
Gene therapy (85)
GLP-1 (210)
Government (2308)
Guidances (38)
Healthcare (7060)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (33)
Indications (18)
Infectious disease (941)
Inflammatory bowel disease (46)
Inflation Reduction Act (3)
Influenza (24)
Intellectual property (61)
Interviews (30)
IPO (11607)
IRA (27)
Job creations (1104)
Job search strategy (217)
Kidney cancer (7)
Labor market (2)
Layoffs (143)
Leadership (1)
Legal (5368)
Liver cancer (25)
Lung cancer (128)
Lymphoma (61)
Management (5)
Manufacturing (109)
MASH (34)
Medical device (5811)
Medtech (5812)
Mergers & acquisitions (9060)
Metabolic disorders (276)
Multiple sclerosis (38)
NASH (8)
Neurodegenerative disease (28)
Neuropsychiatric disorders (7)
Neuroscience (708)
NextGen: Class of 2025 (2043)
Non-profit (981)
Northern California (1292)
Now hiring (2)
Obesity (135)
Opinion (65)
Ovarian cancer (41)
Pain (37)
Pancreatic cancer (40)
Parkinson's disease (37)
Partnered (6)
Patents (156)
Patient recruitment (41)
Peanut (18)
People (19184)
Pharmaceutical (4)
Pharmacy benefit managers (19)
Phase I (8490)
Phase II (13110)
Phase III (11186)
Pipeline (673)
Podcasts (7)
Policy (72)
Postmarket research (1023)
Preclinical (3115)
Press Release (24)
Prostate cancer (49)
Psychedelics (4)
Radiopharmaceuticals (107)
Rare diseases (131)
Real estate (1470)
Recruiting (7)
Regulatory (11616)
Reports (5)
Research institute (439)
Resumes & cover letters (19)
Rett syndrome (2)
RSV (14)
Schizophrenia (28)
Series A (18)
Series B (9)
Sickle cell disease (24)
Southern California (1140)
Special edition (5)
Spinal muscular atrophy (63)
Sponsored (2)
Startups (715)
State (1)
Stomach cancer (2)
Supply chain (26)
The Weekly (5)
United States (10396)
Vaccines (206)
Venture capitalists (7)
Webinars (5)
Weight loss (83)
Women's health (3)
Date
Today (54)
Last 7 days (342)
Last 30 days (1317)
Last 365 days (16232)
2025 (3742)
2024 (17063)
2023 (19611)
2022 (21385)
2021 (24101)
2020 (23693)
2019 (17838)
2018 (14070)
2017 (14887)
2016 (12447)
2015 (15738)
2014 (10928)
2013 (8073)
2012 (8868)
2011 (9397)
2010 (8296)
Location
Africa (199)
Alabama (31)
Alaska (2)
Arizona (60)
Arkansas (4)
Asia (15333)
Australia (2281)
California (2914)
Canada (915)
China (172)
Colorado (130)
Connecticut (115)
Delaware (45)
Europe (31459)
Florida (424)
Georgia (98)
Idaho (19)
Illinois (178)
India (10)
Indiana (168)
Iowa (1)
Japan (47)
Kansas (51)
Kentucky (2)
Louisiana (4)
Maine (36)
Maryland (432)
Massachusetts (1866)
Michigan (61)
Minnesota (132)
Missouri (23)
Montana (12)
Nebraska (5)
Nevada (21)
New Hampshire (38)
New Jersey (895)
New Mexico (2)
New York (924)
North Carolina (322)
North Dakota (2)
Northern California (1292)
Ohio (40)
Oklahoma (3)
Oregon (2)
Pennsylvania (664)
Puerto Rico (4)
Rhode Island (3)
South America (362)
South Carolina (6)
Southern California (1140)
Tennessee (27)
Texas (406)
Utah (98)
Virginia (61)
Washington D.C. (35)
Washington State (281)
West Virginia (1)
Wisconsin (12)
271,508 Results for "federal trade commission".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
AbbVie Lawsuit Alleges That Partner Genmab “Misappropriated” Trade Secrets
AbbVie claims that Genmab turned a blind eye to trade secret theft allegedly used to support the development of ProfoundBio’s investigational antibody-drug conjugates. Genmab acquired ProfoundBio in May 2024.
March 24, 2025
·
2 min read
·
Tristan Manalac
Patents
Patent Thickets in Federal Government’s Crosshairs as Election 2024 Looms
Congress, the Federal Trade Commission and the U.S. Patent and Trademark Office are all targeting Big Pharma’s practice of filing multiple, overlapping patents that stifle generic and biosimilar competition.
August 28, 2024
·
7 min read
·
Greg Slabodkin
Press Releases
Management Cease Trade Order Status Report
March 25, 2025
·
3 min read
Press Releases
Management Cease Trade Order Granted
March 4, 2025
·
2 min read
Press Releases
Neural Therapeutics Commences Trading on Frankfurt Stock Exchange
March 31, 2025
·
5 min read
Press Releases
Full Year Trading Update
March 4, 2025
·
8 min read
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
Government
Judge Blocks FTC Rule That Banned Most New Noncompete Clauses
The federal judge’s decision Tuesday said the Federal Trade Commission exceeded its statutory authority in implementing a final rule aimed at restricting noncompete clauses.
August 21, 2024
·
1 min read
·
Angela Gabriel
Mergers & acquisitions
Unions, Public Interest Groups Call on FTC to Challenge Novo Holdings-Catalent Acquisition
Pressure has been mounting for the Federal Trade Commission to take action, with Senator Elizabeth Warren last week urging FTC Chair Lina Khan to block the merger if it violates antitrust laws.
October 18, 2024
·
2 min read
·
Tristan Manalac
Editorial
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could increase Novo’s dominance over the hot GLP-1 market, reducing competition and increasing prices.
October 11, 2024
·
3 min read
·
Greg Slabodkin
1 of 27,151
Next
